Tag Archives: biotechnology law

Happy Belated Birthday to Patents4Life! We are One.

Posted on March 21, 2010 by Warren Woessner

Last Wednesday, Patents4Life forgot to celebrate its first anniversary. I have done a lot of writing, and recruiting of some writers (particular thanks to Paul Cole of Lucas & Co., UK, and Ronald J. Schutz of Robins Kaplan in Minneapolis … Continue reading →

Posted in About SLW | Tagged , , , , , , , | Leave a comment

Electronics vs. Biotech – Two Perspectives on “Patent Reform”

Posted on March 19, 2010 by Warren Woessner

The most interesting session I attended today at the AUTM Annual Meeting was one on patent reform. What was most interesting was not a recap of the aspects of S.515, which is the most up-to-date reform bill pending, but the … Continue reading →

Posted in Patent Reform Legislation | Tagged , , , , , , , , | Leave a comment

ARIAD v. LILLY – A Modest Proposal – Should Screening be Enough?

Posted on March 5, 2010 by Warren Woessner

As the Fed. Cir. prepares to issue an en banc opinion on the existence and role of the written description requirement in section 112, it seems like a time for reflection. After taking the position that enablement should suffice for … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged , , , | Leave a comment

Hearing fixed for “Broccoli” and “Tomatoes” cases before the EPO Enlarged Board of Appeal, G 0002/07 and G 0001/08

Posted on February 22, 2010 by Warren Woessner

Post from Paul Cole The EPC prohibits patents for essentially biological processes and the referred questions relate to the degree and nature of human technical intervention, which is necessary for that provision not to apply.  Case G 0002/07 “Broccoli” concerns EP-B-1 … Continue reading →

Posted in Non-U.S. Practice | Tagged , , | Leave a comment